Companies

Bharat Biotech rolls out first commercial batch of Covaxin from Ankleshwar

Our Bureau Hyderabad | Updated on August 29, 2021

Mansukh Mandaviya, Union Minister of Health and Family Welfare at the rollout of commercial batch of Covaxin from Bharat Biotech’s Ankleshwar facility   -  Twitter via @mansukhmandviya

The vaccine doses manufactured from Ankleshwar will be available for supply starting September 2021.

Bharat Biotech International Pvt. Ltd has rolled out the first commercial batch of Covid19 vaccine Covaxin manufactured in its Chiron Behring facility, Ankleshwar, Gujarat.

The vaccine doses manufactured from Ankleshwar will be available for supply starting September 2021.

The company has already deployed multiple production lines at its Hyderabad, Malur, Bengaluru, and Pune campuses, and with the addition of Chiron Behring facility, Ankleshwar this will further augment its Covaxin's production capacity.

Chiron Behring Vaccines is a wholly owned subsidiary of Bharat Biotech. The new filing facility constructed during 2020 is now being utilized for the production of vaccine.

Speaking after the formal launch, Mansukh Mandaviya, Union Minister of Health and Family Welfare, said: "We want to ensure equitable access of the vaccine to every Indian citizen, and the expansion of Covaxin production facilities by Bharat Biotech will take us closer to this goal."

Krishna Ella, Chairman & Managing Director, Bharat Biotech, said "Our goal to develop a vaccine with global safety and efficacy standards has now been achieved, we are now marching towards the goal of annualized capacity of about one billion doses.”

Suchitra Ella, Joint Managing Director, Bharat Biotech, said, “I am happy to share that our efforts over the last one year have fructified, and we are now several steps closer to achieving our goal of providing Covaxin to all pockets of the country and overseas. "

With specialised bio safety containment facilities in Hyderabad, Malur, Ankleshwar, and Pune, Bharat Biotech steadily moves towards its aim of about one billion doses of annualised capacity.

Published on August 29, 2021

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor

You May Also Like